262 related articles for article (PubMed ID: 19109526)
1. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM
Am J Physiol Cell Physiol; 2009 Mar; 296(3):C476-88. PubMed ID: 19109526
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A.
Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT
Am J Pathol; 2007 Jul; 171(1):181-99. PubMed ID: 17591965
[TBL] [Abstract][Full Text] [Related]
4. rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.
Xu R; Jia Y; Zygmunt DA; Martin PT
Mol Ther; 2019 Mar; 27(3):636-649. PubMed ID: 30711447
[TBL] [Abstract][Full Text] [Related]
5. Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.
Xu R; Camboni M; Martin PT
Neuromuscul Disord; 2007 Mar; 17(3):209-20. PubMed ID: 17300937
[TBL] [Abstract][Full Text] [Related]
6. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
Chandraskeharan K; Martin PT
Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
[TBL] [Abstract][Full Text] [Related]
7. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Xu R; DeVries S; Camboni M; Martin PT
Am J Pathol; 2009 Jul; 175(1):235-47. PubMed ID: 19498002
[TBL] [Abstract][Full Text] [Related]
9. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
10. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
[TBL] [Abstract][Full Text] [Related]
11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
12. B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
Thomas PJ; Xu R; Martin PT
Am J Pathol; 2016 Sep; 186(9):2429-48. PubMed ID: 27561302
[TBL] [Abstract][Full Text] [Related]
13. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
[TBL] [Abstract][Full Text] [Related]
14. The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: Partial dependence on utrophin.
Yoon JH; Chandrasekharan K; Xu R; Glass M; Singhal N; Martin PT
Mol Cell Neurosci; 2009 Aug; 41(4):448-63. PubMed ID: 19442736
[TBL] [Abstract][Full Text] [Related]
15. Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction.
Singhal N; Xu R; Martin PT
Mol Cell Neurosci; 2012 Nov; 51(3-4):112-26. PubMed ID: 22982027
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal muscle.
Roy P; Rau F; Ochala J; Messéant J; Fraysse B; Lainé J; Agbulut O; Butler-Browne G; Furling D; Ferry A
Skelet Muscle; 2016; 6():23. PubMed ID: 27441081
[TBL] [Abstract][Full Text] [Related]
18. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.
Chan S; Head SI; Morley JW
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C985-92. PubMed ID: 17567750
[TBL] [Abstract][Full Text] [Related]
19. Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss.
Call JA; Warren GL; Verma M; Lowe DA
J Physiol; 2013 Aug; 591(15):3765-76. PubMed ID: 23753524
[TBL] [Abstract][Full Text] [Related]
20. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]